AnneFreyLuetkemeyerMD
Infectious Disease • San Francisco, CAAssistant Professor, Medicine, UCSF School of Medicine
Dr. Luetkemeyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
995 Potrero Ave
Box 0874
San Francisco, CA 94110Phone+1 415-476-4082Fax+1 415-476-6953
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 2003 - 2006- University of California (San Francisco)Residency, Internal Medicine, 1999 - 2002
Harvard Medical SchoolClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection Start of enrollment: 2008 Apr 01
- A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C Start of enrollment: 2014 Aug 01
- Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men Start of enrollment: 2019 Nov 26
Publications & Presentations
PubMed
- Another Tool for the Sexual Health Toolkit: US Health Care Provider Knowledge and Attitudes About Doxycycline Postexposure Prophylaxis to Prevent Bacterial Sexually Tr...Rodney Perkins, Kristin Beima-Sofie, Katerina Christopoulos, Stephanie E Cohen, Aurnell Dright
Sexually Transmitted Diseases. 2025-03-01 - Reply to Keyon.Aniruddha Hazra, Connie Celum, Anne F Luetkemeyer, Jean-Michel Molina, Jeffrey D Klausner
Clinical Infectious Diseases. 2025-02-05 - 1 citationsNeutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.Youyi Fong, Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen
Clinical Infectious Diseases. 2025-02-05
Press Mentions
Antibiotic Cuts Risk of HIV, STDs After Exposure, Study SaysMay 8th, 2023- Doxy-PEP for STIs and More: Dr. Dieffenbach’s Highlights from Day 1 of CROI 2023February 21st, 2023
- Meta-Analysis Supports COVID-19 Mortality Benefit with IL-6 InhibitorsJuly 15th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
